The PCRT mission is to organize and accelerate the clinical development of new agents for the treatment of patients with pancreatic cancer. PCRT is an international collaborative organization formed by several world renowned institutions and researchers. PCRT conducts clinical trials in patients with pancreatic cancer, translating genomics research into prevention, diagnosis and treatment.

PCRT members include laboratory and clinical researchers in the U.S. and Europe, who share the passion to rapidly bring new advances to pancreatic cancer patients; PCRT provides the only coordinated effort in the world dedicated to swiftly translating research discoveries into new treatments and supportive care for patients with pancreatic cancer. All phases of clinical research are supported through PCRT.

To date, the PCRT consortium includes approximately 75 Oncology Clinicians, Surgeons and Researchers who are member-investigators of PCRT representing 45 research sites.

PCRT is a program within Cancer Research And Biostatistics (CRAB), headquartered in Seattle, WA, a non-profit corporation formed under Section 501(c)(3) of the Internal Revenue Code. As such, PCRT and CRAB rely on state and federal funding, along with the generous backing of concerned individuals, businesses, and foundations to allow this important clinical trial research to happen. All contributions can make a difference to pancreatic cancer. Donations and support are an important cornerstone of bringing new treatment options to a much needed patient population. To make a donation, please go to our Support page.